These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 549632

  • 1. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP, Diloy-Puray M, Streczyn M.
    Biochim Biophys Acta; 1979 Oct 19; 557(1):149-55. PubMed ID: 549632
    [Abstract] [Full Text] [Related]

  • 2. Erythrocyte membrane lipid reorganization during the sickling process.
    Chiu D, Lubin B, Shohet SB.
    Br J Haematol; 1979 Feb 19; 41(2):223-34. PubMed ID: 427032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of Ca2+-dependent biochemical changes in the ageing process in normal red cells and in the development of irreversibly sickled cells.
    Allan D, Raval PJ.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987 Feb 19; 114(4):499-503. PubMed ID: 2446988
    [Abstract] [Full Text] [Related]

  • 8. Sialic acid in sickle cell disease.
    Ekeke GI, Ibeh GO.
    Clin Chem; 1988 Jul 19; 34(7):1443-6. PubMed ID: 3390914
    [Abstract] [Full Text] [Related]

  • 9. Cell-bound autologous immunoglobulin in erythrocyte subpopulations from patients with sickle cell disease.
    Green GA, Rehn MM, Kalra VK.
    Blood; 1985 May 19; 65(5):1127-33. PubMed ID: 3888304
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of valinomycin, A23187 and repetitive sickling on irreversible sickle cell formation.
    Westerman MP, Allan D.
    Br J Haematol; 1983 Mar 19; 53(3):399-409. PubMed ID: 6402002
    [Abstract] [Full Text] [Related]

  • 14. The irreversibly sickled cell.
    Smith CM, Krivit W, White JG.
    Am J Pediatr Hematol Oncol; 1982 Mar 19; 4(3):307-15. PubMed ID: 7149169
    [Abstract] [Full Text] [Related]

  • 15. Membrane phospholipid abnormalities in pathologic erythrocytes: a model for cell aging.
    Wagner G, Chiu DT, Schwartz RS, Lubin B.
    Prog Clin Biol Res; 1985 Mar 19; 195():237-50. PubMed ID: 4059270
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells.
    Franck PF, Bevers EM, Lubin BH, Comfurius P, Chiu DT, Op den Kamp JA, Zwaal RF, van Deenen LL, Roelofsen B.
    J Clin Invest; 1985 Jan 19; 75(1):183-90. PubMed ID: 3965502
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.